Gero introduced ProtoBind-Diff, a structure-free diffusion language model that designs drug-like molecules guided solely by protein amino acid sequences. Trained on over a million protein-ligand pairs, it matches or surpasses structure-based methods, facilitating discovery for underexplored targets. Separately, Google DeepMind launched AlphaGenome, an AI model predicting the effects of DNA variations on gene regulation, merging diverse genomic challenges into one platform. These AI innovations enhance molecular design and functional genomics, accelerating biotech research and therapeutic development.